Discovery of betulinaldehyde as a natural RORγt agonist

Fitoterapia. 2019 Sep:137:104200. doi: 10.1016/j.fitote.2019.104200. Epub 2019 Jun 10.

Abstract

Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) is a dual-functional therapeutic target. The agonists and inhibitors of RORγt are potential agents for tumor immunotherapy and autoimmune diseases, respectively, and sometimes share similar scaffolds. Although the widely distributed triterpenoid ursolic acid (UA) has been identified as a RORγt inhibitor, the report of a triterpenoid RORγt agonist is still absent. By screening an in-house triterpenoid library, we uncovered a novel RORγt agonist, betulinaldehyde (1), together with an inhibitor (2, 3β, 28-Dihydroxy-lupan-29-oic acid). Compound 1 showed a good RORγt activating effect with the EC50 of 11.4 μM in Alpha Screen assay, and altered the thermal stability of RORγt by directly binding to the protein in vitro. Combined with the SPR assay, the Kd value of compound 1 was examined as 2.99 μM. The modulation mechanism of triterpenoid agonists and inhibitors were discussed by molecular docking. Herein, we firstly discovered compound 1 as a triterpenoid agonist of RORγt. The co-distribution of triterpenoid RORγt agonist and inhibitors in the same plant, might be related to the anti-inflammatory and anti-cancerous bioactivity of the plant extract.

Keywords: Alpha screen; Molecular docking; RORγt; Receptor agonist; Triterpenoids.

MeSH terms

  • Aldehydes / pharmacology*
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / agonists*
  • Phytochemicals / pharmacology
  • Triterpenes / pharmacology*

Substances

  • Aldehydes
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • Phytochemicals
  • RORC protein, human
  • Triterpenes